An official website of the United States government
          Here’s how you know
        Here’s how you know**Official websites use .gov**A
              **.gov** website belongs to an official government
              organization in the United States.
        **Secure .gov websites use HTTPS**A
              **lock** (
              Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 Top Utility Nav
        
        
        Asian-Language Resources
        
        Portal en español


Site search Mega Menu
  

        

        Home
                  Health Topics
                                      
    
  Health Topics

    Arthritis and Rheumatic Diseases
          
    Muscle and Bone Diseases
          
    Skin Diseases
          
    All Diseases and Conditions
          
    Publication Catalog
                  Grants & Funding
                                      
    
  Grants & Funding

    Current Funding Opportunities
          
    Supported Scientific Programs
          
    NIAMS-Supported Programs
          
    Applying for a Grant
          
    NIH Policies and Guidance
          
    Peer Review and Grants Administration Resources
          
    Types of Funding Mechanisms (Activity Codes)
                  Labs @ NIAMS
                                      
    
  Labs @ NIAMS

    NIAMS Labs and Core Facilities
          
    Research Faculty
          
    Research Areas
          
    NIAMS Scientific Advances
          
    Training and Career Development
                  Clinical Trials
                                      
    
  Clinical Trials
      
            For Principal Investigators

    Clinical Trial Policies, Guidelines, and Templates
          
    Conducting Clinical Trials
          
    Register with ClinicalTrials.gov

For Patients

What is a Clinical Trial?
	Clinical Trials at NIAMS
	Clinical Trials in the Spotlight
                  News & Events
                                      
    
  Newsroom

    All NIAMS News
          
    NIAMS Newsletters
          
    Meetings & Events
                  About NIAMS
                                      
    
  About NIAMS

    Director's Page
          
    NIAMS Organization
          
    Strategic Plan Fiscal Years 2020-2024
          
    Staff Directory
          
    NIAMS Budget
          
    Partnerships
          
    Contact NIAMS
                  Community Outreach
                                      
    
  Community Outreach

    Bone Health
          
    Joint Health
          
    Muscle, Tendon, and Ligament Health
          
    Skin Health
          
    Health Information For Kids And Young Adults
          
    Health Information For Older Adults/Seniors
          
    Printable Materials for Community Events
          
    Resources in Other Languages
          
    Annual Health Observances
          
    Social Media Resources Breadcrumb
    Home
          Labs @ NIAMS
          Dermatology Consultation Service








Dermatology Consultation Service


Edward W. Cowen, M.D., M.H.Sc. FacebookEmailPrintFacebookEmail
        Image
              Montage of medical staff studying skin.

      Overview

                                  Senior Clinician
      
  


Edward W. Cowen, M.D., M.H.Sc.
      
  


            cowene@mail.nih.gov
      
                                                                        

  
   Research Areas (IRP Lab Groups)
          Clinical Research,
          Immunology,
          Skin Biology
                                
            Through the Dermatology Consultation Service at the NIH Clinical Center, patients with a variety of rare diseases with cutaneous manifestations are evaluated. In addition, patients who experience adverse reactions to experimental therapeutic agents or manifest unrelated skin conditions while at the NIH are assessed and treated. We provide training to Dermatology Branch clinical fellows, fellows from other NIH Institutes, and visiting dermatology residents from around the country. 'Grand Rounds at the NIH', an ongoing feature published in the Journal of the American Academy of Dermatology, selects and highlights interesting cases that we have evaluated.Dr. Cowen's primary research interest involves chronic graft-versus-host disease (cGVHD) and autoinflammatory diseases. He is Co-Study Chair of a multi-disciplinary NIH initiative aimed at the study and treatment of cGVHD (04-C-0281) and Principal Investigator of a therapeutic study of topical ruxolitinib for cutaneous cGVHD (18-AR-0035).
      

                                            Related NIAMS LabsCutaneous Development and Carcinogenesis LaboratoryCutaneous Leukocyte Biology LaboratoryCutaneous Microbiome and Inflammation Laboratory
  Scientific Advances
      
  

      September 16, 2022Manual Counting Versus Artificial Intelligence in Assessing Monkeypox Lesions Using Patient Photographs

                                                      Core Research Facilities

Labs at the NIAMS are supported by the following state-of-the-art facilities and services:

Biodata Mining and Discovery
	Flow Cytometry
	Genomic Technology
	Laboratory Animal Care and Use
	Light Imaging
	Translational Immunology

                                    Staff
                            
            **Edward W. Cowen, M.D., M.H.Sc.**Senior Cliniciancowene@mail.nih.gov
    **Olanda M. Hathaway, C.R.N.P.**Nurse Practitionerhathaway@mail.nih.gov
    **Kelli A. Karacki, M.S., PA-C**Physician Assistantkelli.karacki@nih.gov
      

              
                            Former Lab Members
              Clinical FellowsRachel Rosenstein, M.D., Ph.D.Dominique Pichard, M.D., M.H.Sc.Medical StudentsSuzanne Ward, M.D. (Dermatology)Rena Zuo, M.D. (Dermatology)Kathryn Martires, M.D. (Dermatology)Asha Patel, M.D. (Dermatology)
            
                                    
                        
                                    Clinical Trials
              
              
            RecruitingEvaluation and Treatment of Subjects With Dermatologic DiseasesClinicalTrials.gov Identifier: NCT00001506This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. This protocol was developed to allow subject enrollment for teaching purposes and to allow for second opinions regarding relatively complicated patients, and to allow for evaluation of non-invasive tools for the diagnosis and monitoring of cutaneous manifestations.
            
                                    Scientific Publications
              Selected Recent Publications
                  
      Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease.

    Rosenstein RK, Rose JJ, Brooks SR, Tsai WL, Gadina M, Pavletic SZ, Nagao K, Cowen EW
        

                    JID Innov.
        
                    2024 Mar;
        
                    4(2).
        
                    doi: 10.1016/j.xjidi.2023.100246
                            PMID: 38357212
              Host-Pathogen Interactions in Human Polyomavirus 7‒Associated Pruritic Skin Eruption.

    Rosenstein RK, Pastrana DV, Starrett GJ, Sapio MR, Hill NT, Jo JH, Lee CR, Iadarola MJ, Buck CB, Kong HH, Brownell I, Cowen EW
        

                    J Invest Dermatol.
        
                    2021 May;
        
                    141(5).
        
                    doi: 10.1016/j.jid.2020.09.014
                            PMID: 33075349
              Quality of Life in Patients With Skin of Color and Chronic Graft-vs-Host Disease.

    Smith ZI, Rosenstein RK, Banerjee S, Pichard DC, Pavletic SZ, Cowen EW
        

                    JAMA Dermatol.
        
                    2020 May 1;
        
                    156(5).
        
                    doi: 10.1001/jamadermatol.2019.4857
                            PMID: 32049308
              Rehabilitation Interventions in the Multidisciplinary Management of Patients With Sclerotic Graft-Versus-Host Disease of the Skin and Fascia.

    Molés-Poveda P, Comis LE, Joe GO, Mitchell SA, Pichard DC, Rosenstein RK, Solomon B, Pavletic SZ, Cowen EW
        

                    Arch Phys Med Rehabil.
        
                    2021 Apr;
        
                    102(4).
        
                    doi: 10.1016/j.apmr.2020.10.141
                            PMID: 33347890
              Distribution and Functional Consequences of Somatic MAP2K1 Variants in Affected Skin Associated with Bone Lesions in Melorheostosis.

    Jha S, Ivovic A, Kang H, Meylan F, Hanson EP, Rimland C, Lange E, Katz J, McBride A, Warner AC, Edmondson EF, Cowen EW, Marini JC, Siegel RM, Bhattacharyya T
        

                    J Invest Dermatol.
        
                    2021 Mar;
        
                    141(3).
        
                    doi: 10.1016/j.jid.2020.06.036
                            PMID: 32791068
              Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host Disease.

    Saardi KM, Rosenstein RK, Anadkat MJ, Micheletti RG, Schiffenbauer AI, Pavletic SZ, Cowen EW
        

                    JAMA Dermatol.
        
                    2020 Jul 1;
        
                    156(7).
        
                    doi: 10.1001/jamadermatol.2020.1157
                            PMID: 32432645
              Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.

    D'Arcy ME, Pfeiffer RM, Rivera DR, Hess GP, Cahoon EK, Arron ST, Brownell I, Cowen EW, Israni AK, Triplette MA, Yanik EL, Engels EA
        

                    JAMA Dermatol.
        
                    2020 Jul 1;
        
                    156(7).
        
                    doi: 10.1001/jamadermatol.2020.1141
                            PMID: 32401271
                
                                Key Publications
                  
            Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis.

    Kim H, Dill S, O'Brien M, Vian L, Li X, Manukyan M, Jain M, Adeojo LW, George J, Perez M, Grom AA, Sutter M, Feldman BM, Yao L, Millwood M, Brundidge A, Pichard DC, Cowen EW, Shi Y, Lu S, Tsai WL, Gadina M, Rider LG, Colbert RA
            Ann Rheum Dis.
            2020 Aug 25;
            pii: annrheumdis-2020-218690. doi: 10.1136/annrheumdis-2020-218690
            PMID: 32843325

Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease.

    Hymes SR, Alousi AM, Cowen EW
            J Am Acad Dermatol.
            2012 Apr;
            66(4).
            doi: 10.1016/j.jaad.2011.11.960
            PMID: 22421123

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease.

    Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM, Mitchell SA, Datiles M, Hakim FT, Pavletic SZ, Cowen EW
            Blood.
            2011 Oct 13;
            118(15).
            doi: 10.1182/blood-2011-04-350249
            PMID: 21791415

Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.

    Cowen EW, Nguyen JC, Miller DD, McShane D, Arron ST, Prose NS, Turner ML, Fox LP
            J Am Acad Dermatol.
            2010 Jan;
            62(1).
            doi: 10.1016/j.jaad.2009.09.033
            PMID: 19896749

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.
    Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, Laxer R, Tedgård U, Cowen EW, Pham TH, Booty M, Estes JD, Sandler NG, Plass N, Stone DL, Turner ML, Hill S, Butman JA, Schneider R, Babyn P, El-Shanti HI, Pope E, Barron K, Bing X, Laurence A, Lee CC, Chapelle D, Clarke GI, Ohson K, Nicholson M, Gadina M, Yang B, Korman BD, Gregersen PK, van Hagen PM, Hak AE, Huizing M, Rahman P, Douek DC, Remmers EF, Kastner DL, Goldbach-Mansky R
            N Engl J Med.
            2009 Jun 4;
            360(23).
            doi: 10.1056/NEJMoa0807865
            PMID: 19494218

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
    Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW, Turner ML, Akpek G, Gilman A, McDonald G, Schubert M, Berger A, Bross P, Chien JW, Couriel D, Dunn JP, Fall-Dickson J, Farrell A, Flowers ME, Greinix H, Hirschfeld S, Gerber L, Kim S, Knobler R, Lachenbruch PA, Miller FW, Mittleman B, Papadopoulos E, Parsons SK, Przepiorka D, Robinson M, Ward M, Reeve B, Rider LG, Shulman H, Schultz KR, Weisdorf D, Vogelsang GB, Response Criteria Working Group.        
            Biol Blood Marrow Transplant.
            2006 Mar;
            12(3). 
                            See more publications at PubMed



    FacebookEmailPrintFacebookEmail
        Last Updated: March 2024
 About NIAMS
                    Clinical Trials
                    Grants & Funding
                    Health Topics
                    Labs @ NIAMS
              News Room
                    NIAMS Multimedia Library
                    Disclaimer
                    FOIA
                    Contact us
              Privacy Statement
                    Accessibility
                    HHS Vulnerability Disclosure
                    Social Media Moderation Policy
                    NIAMS Archives
        Subscribe to Our E-Newsletters
            Click the button to see different options to sign up for newsletters.
            Click Here to Subscribe
          Follow us on
  
  About NIH
                  Accessibility Support
            FOIA requests
                  No FEAR Act data
            Office of the Inspector General
                  Performance reports
            Privacy Policy Back to Top